Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ISRCTN17231220) titled 'Process Optimization Of the Medicines' pAthway in nursing Homes' on May 7.
Study Type: Interventional
Study Design:
Multi-arm pre-post cluster randomized controlled trial (Other, Safety, Efficacy)
Primary Sponsor: KU Leuven
Condition:
Improvement of the quality of the medicines' pathway in nursing homes
Other
Intervention:
Nursing homes (NHs) are allocated to one of the four support programs, receiving different formats and intensities of support during one year (2025).
NHs in Program 1 gain access to a (mostly digital) toolbox. NHs in Program 2 gain access to that same toolbox, and take part in intervisi...